Gabelli & Co Investment Advisers’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-69,175	Closed	-$2.75M	–	193
2016 Q3	$2.75M	Buy	+69,175	New	+$772K	0.32%	59

Gabelli & Co Investment Advisers's TBRA Position: Q4 2016 in Review

Gabelli & Co Investment Advisers sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 69,175 shares — an estimated $2.75M sold.

Gabelli & Co Investment Advisers first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $2.75M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Gabelli & Co Investment Advisers reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 69,175 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.75M.
Gabelli & Co Investment Advisers first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Tobira Therapeutics, Inc. Common Stock position peaked at $2.75M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2016, filed 10 Feb 2017.